BBKK的个人主页 - 老虎社区

BBKK

BBKK

暂无个人介绍

IP属地：未知

46关注

2粉丝

0主题

0勋章

2021-08-05

Nice share

抱歉，原内容已删除

2021-08-05

Nice

抱歉，原内容已删除

2021-08-05

Nice

抱歉，原内容已删除

2021-08-03

Share

2021-07-30

Good to know

抱歉，原内容已删除

2021-07-29

Ok good

抱歉，原内容已删除

2021-07-28

Good to know

抱歉，原内容已删除

2021-07-28

Wow

Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>

2021-07-26

Like.

抱歉，原内容已删除

2021-07-26

Oops

2021-07-23

Test test

2021-07-23

Test test,

2021-07-23

Up…

2021-07-20

Good to know. [Smile]

抱歉，原内容已删除

2021-07-20

Good to know

抱歉，原内容已删除

2021-07-20

Liked …. Someone pls like my comment? Thanks

抱歉，原内容已删除

2021-07-19

Good to know this

抱歉，原内容已删除

2021-07-19

Good to know this

抱歉，原内容已删除

2021-07-19

Ok! Good

Moderna Surges to Record High as Vaccine Maker Added to S&P 500<blockquote>随着疫苗制造商加入标普500，Moderna股价飙升至历史新高</blockquote>

2021-07-19

Ok

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4089409912576010","uuid":"4089409912576010","gmtCreate":1626356565599,"gmtModify":1626360568573,"name":"BBKK","pinyin":"bbkk","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":46,"tweetSize":29,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":890506478,"gmtCreate":1628122445694,"gmtModify":1633753440793,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Nice share&nbsp;","listText":"Nice share&nbsp;","text":"Nice share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/890506478","repostId":"2157488120","repostType":4,"isVote":1,"tweetType":1,"viewCount":2234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890506959,"gmtCreate":1628122429071,"gmtModify":1633753441504,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890506959","repostId":"2157488120","repostType":4,"isVote":1,"tweetType":1,"viewCount":3769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890508171,"gmtCreate":1628122416093,"gmtModify":1633753442295,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890508171","repostId":"2157488120","repostType":4,"isVote":1,"tweetType":1,"viewCount":2151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804174403,"gmtCreate":1627948235002,"gmtModify":1633755077351,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Share&nbsp;","listText":"Share&nbsp;","text":"Share","images":[{"img":"https://static.tigerbbs.com/4a4c0f57dfa9fc13d04eca25cc1b1197","width":"1125","height":"3060"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804174403","isVote":1,"tweetType":1,"viewCount":2418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":806011583,"gmtCreate":1627616029242,"gmtModify":1633757730731,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know&nbsp;","listText":"Good to know&nbsp;","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/806011583","repostId":"2155133648","repostType":4,"isVote":1,"tweetType":1,"viewCount":2629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801855921,"gmtCreate":1627511653763,"gmtModify":1633764399710,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Ok good&nbsp;","listText":"Ok good&nbsp;","text":"Ok good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801855921","repostId":"1179923360","repostType":4,"isVote":1,"tweetType":1,"viewCount":2034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803194065,"gmtCreate":1627427241357,"gmtModify":1633765216080,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know&nbsp;","listText":"Good to know&nbsp;","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/803194065","repostId":"2154915475","repostType":4,"isVote":1,"tweetType":1,"viewCount":3455,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803192165,"gmtCreate":1627427169857,"gmtModify":1633765217806,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/803192165","repostId":"1134472085","repostType":4,"repost":{"id":"1134472085","kind":"news","pubTimestamp":1627398407,"share":"https://www.laohu8.com/m/news/1134472085?lang=zh_CN&edition=full","pubTime":"2021-07-27 23:06","market":"us","language":"en","title":"Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134472085","media":"TheStreet","summary":"On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. ","content":"<p>On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.</p><p><blockquote>7 月 28 日星期三，制药商 Tilray 将公布第四财季盈利结果。华尔街模因讨论这是否是一个很好的买入机会。</blockquote></p><p> Drug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.</p><p><blockquote>药品制造商 Tilray 是一家总部位于加拿大的从事医用大麻研究、种植和分销的公司，即将公布第四财季业绩。</blockquote></p><p> The stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.</p><p><blockquote>该股票在 2021 年受到 Redditor 用户的欢迎。随着财报日即将到来，现在的问题是，以目前的价格来看，TLRY 是否值得购买。</blockquote></p><p> <b>The cannabis market</b></p><p><blockquote><b>大麻市场</b></blockquote></p><p> In the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according&nbsp;to the latest data.</p><p><blockquote>在美国，共有34个州加上哥伦比亚特区认为大麻用于医疗用途是合法的。根据最新数据，其中16个已被批准用于娱乐用途。</blockquote></p><p> In 2020, the cannabis market was&nbsp;estimated&nbsp;to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.</p><p><blockquote>根据New Frontier Data的数据，2020年大麻市场价值估计为200亿美元，预计到2025年将达到430亿美元。社会对大麻的接受和生产监管框架的发展似乎推动了增长。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/703f3ea081e0c6f7d74ae53891810b24\" tg-width=\"1240\" tg-height=\"859\" width=\"100%\" height=\"auto\"><span>Figure 1: Annual growth of the U.S legal cannabis industry.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：美国合法大麻产业的年增长率。</span></p></blockquote></p><p> <b>Tilray + Aphria merger</b></p><p><blockquote><b>Tilray + Aphria 合并</b></blockquote></p><p> Tilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.</p><p><blockquote>Tilray 自 2020 年 12 月与 Aphria 合并后开始公开交易。交易完成后，TLRY现在的市值接近60亿美元，是当今最大的大麻公司之一，与同行Canopy Growth并驾齐驱。</blockquote></p><p> The Tilray-Aphria merger was justified by expected benefits that included:</p><p><blockquote>Tilray-Aphria 合并的预期好处包括：</blockquote></p><p> <ol>  <li>market leadership in Canada</li>  <li>foothold in Europe and better positioning in the U.S.</li>  <li>lower production costs and synergies</li> </ol> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6577d25764f8877328fad35a1d14e2d\" tg-width=\"1240\" tg-height=\"659\" width=\"100%\" height=\"auto\"><span>Figure 2: Aphria + Tilray merger.</span></p><p><blockquote><ol><li>加拿大市场领导地位</li><li>在欧洲站稳脚跟，在美国有更好的定位。</li><li>降低生产成本和协同效应</li></ol><p class=\"t-img-caption\"><span>图2：Aphria+Tilray合并。</span></p></blockquote></p><p> <b>Wall Street's take</b></p><p><blockquote><b>华尔街的观点</b></blockquote></p><p> In the past several quarters, Tilray has been making good strides on its P&amp;L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:</p><p><blockquote>在过去的几个季度里，Tilray 的损益表取得了良好的进展。2020年，该公司报告的收入逐步改善，全年达到2.1亿美元。它还成功扭转了自去年之前积累的大幅净亏损状况。见下文：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ee35f0e1943629cac6c9a31ffdb5ca8\" tg-width=\"1240\" tg-height=\"481\" width=\"100%\" height=\"auto\"><span>Figure 3: Tilray earnings and revenues.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 3：Tilray 盈利和收入。</span></p></blockquote></p><p> Analysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.</p><p><blockquote>分析师目前将 TLRY 评级为适度买入，平均目标价接近 21 美元，潜在上涨空间为 52%。与 Aphria 的合并对大多数分析师产生了积极影响。</blockquote></p><p> Despite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen &amp; Co.’s analyst&nbsp;maintained&nbsp;her buy recommendation, but stated the following about Tilray:</p><p><blockquote>尽管这些指标令人鼓舞，但华尔街最近对该公司和股票的一些评论一直持谨慎态度。上个月，Cowen &amp; Co. 的分析师维持了买入建议，但对 Tilray 的评价如下：</blockquote></p><p>   \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.”  Alliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.</p><p><blockquote>“我们正在下调我们的收入和EBITDA预期，因为我们预计加拿大的COVID挑战仍将是一个阻力。此外，TLRY面临着严峻的市场份额竞争，在与Aphria完成合并后，它已经从峰值水平回落并趋于稳定。”Alliance Global Partners对TLRY的评级为中性。分析师不太乐观，将目标价从 32 美元下调至 18 美元。他表示，与 Aphria 的合并对该股有利，但价格在当前水平上是公平的。</blockquote></p><p> <b>Reddit popularity</b></p><p><blockquote><b>Reddit 人气</b></blockquote></p><p> Tilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.</p><p><blockquote>Tilray 股票在 2021 年 2 月见证了令人瞠目结舌的上涨。1 月初至 2 月初期间，股价上涨了 670% 以上，然后急剧回落。</blockquote></p><p> The drivers of bullishness were (1) good earnings results, (2) favorable&nbsp;developments&nbsp;in cannabis regulation, and (2) the signed&nbsp;agreement&nbsp;with Grow Pharma to distribute medical cannabis for patients in the U.K.</p><p><blockquote>看涨的驱动因素是 (1) 良好的盈利业绩，(2) 大麻监管的有利发展，以及 (2) 与 Grow Pharma 签署的向英国患者分销医用大麻的协议。</blockquote></p><p> Reddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.</p><p><blockquote>Reddit论坛似乎也发挥了作用。迷因狂热在一月下旬开始升温，最初是在游戏驿站。很快，TLRY 等其他股票也受益。请参阅下面的股价历史记录以及华尔街投注的评论量。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/12016274a218bd36961f141e5af0556b\" tg-width=\"1160\" tg-height=\"840\" width=\"100%\" height=\"auto\"><span>Figure 4: TLRY stock sentiment and popularity on the WSB.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 4：TLRY 股票情绪和 WSB 上的受欢迎程度。</span></p></blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街迷因的看法</b></blockquote></p><p> The cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.</p><p><blockquote>大麻行业对监管因素非常敏感。缺乏有关新大麻法规的积极消息可能会导致股价长期低迷，就像当前的股价一样。此外，在最近的合并之后，Tilray 还面临着通常的整合风险。</blockquote></p><p></p><p> At the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.</p><p><blockquote>与此同时，随着美国和全球其他地方大麻的医疗和娱乐用途的扩大，机会继续存在。从股票评级和目标价来看，华尔街分析师似乎仍然看好该股。最后，随着Reddit人群的关注，TLRY未来可能会再次成为模因攻击的目标。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-07-27 23:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p>On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.</p><p><blockquote>7 月 28 日星期三，制药商 Tilray 将公布第四财季盈利结果。华尔街模因讨论这是否是一个很好的买入机会。</blockquote></p><p> Drug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.</p><p><blockquote>药品制造商 Tilray 是一家总部位于加拿大的从事医用大麻研究、种植和分销的公司，即将公布第四财季业绩。</blockquote></p><p> The stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.</p><p><blockquote>该股票在 2021 年受到 Redditor 用户的欢迎。随着财报日即将到来，现在的问题是，以目前的价格来看，TLRY 是否值得购买。</blockquote></p><p> <b>The cannabis market</b></p><p><blockquote><b>大麻市场</b></blockquote></p><p> In the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according&nbsp;to the latest data.</p><p><blockquote>在美国，共有34个州加上哥伦比亚特区认为大麻用于医疗用途是合法的。根据最新数据，其中16个已被批准用于娱乐用途。</blockquote></p><p> In 2020, the cannabis market was&nbsp;estimated&nbsp;to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.</p><p><blockquote>根据New Frontier Data的数据，2020年大麻市场价值估计为200亿美元，预计到2025年将达到430亿美元。社会对大麻的接受和生产监管框架的发展似乎推动了增长。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/703f3ea081e0c6f7d74ae53891810b24\" tg-width=\"1240\" tg-height=\"859\" width=\"100%\" height=\"auto\"><span>Figure 1: Annual growth of the U.S legal cannabis industry.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：美国合法大麻产业的年增长率。</span></p></blockquote></p><p> <b>Tilray + Aphria merger</b></p><p><blockquote><b>Tilray + Aphria 合并</b></blockquote></p><p> Tilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.</p><p><blockquote>Tilray 自 2020 年 12 月与 Aphria 合并后开始公开交易。交易完成后，TLRY现在的市值接近60亿美元，是当今最大的大麻公司之一，与同行Canopy Growth并驾齐驱。</blockquote></p><p> The Tilray-Aphria merger was justified by expected benefits that included:</p><p><blockquote>Tilray-Aphria 合并的预期好处包括：</blockquote></p><p> <ol>  <li>market leadership in Canada</li>  <li>foothold in Europe and better positioning in the U.S.</li>  <li>lower production costs and synergies</li> </ol> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6577d25764f8877328fad35a1d14e2d\" tg-width=\"1240\" tg-height=\"659\" width=\"100%\" height=\"auto\"><span>Figure 2: Aphria + Tilray merger.</span></p><p><blockquote><ol><li>加拿大市场领导地位</li><li>在欧洲站稳脚跟，在美国有更好的定位。</li><li>降低生产成本和协同效应</li></ol><p class=\"t-img-caption\"><span>图2：Aphria+Tilray合并。</span></p></blockquote></p><p> <b>Wall Street's take</b></p><p><blockquote><b>华尔街的观点</b></blockquote></p><p> In the past several quarters, Tilray has been making good strides on its P&amp;L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:</p><p><blockquote>在过去的几个季度里，Tilray 的损益表取得了良好的进展。2020年，该公司报告的收入逐步改善，全年达到2.1亿美元。它还成功扭转了自去年之前积累的大幅净亏损状况。见下文：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ee35f0e1943629cac6c9a31ffdb5ca8\" tg-width=\"1240\" tg-height=\"481\" width=\"100%\" height=\"auto\"><span>Figure 3: Tilray earnings and revenues.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 3：Tilray 盈利和收入。</span></p></blockquote></p><p> Analysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.</p><p><blockquote>分析师目前将 TLRY 评级为适度买入，平均目标价接近 21 美元，潜在上涨空间为 52%。与 Aphria 的合并对大多数分析师产生了积极影响。</blockquote></p><p> Despite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen &amp; Co.’s analyst&nbsp;maintained&nbsp;her buy recommendation, but stated the following about Tilray:</p><p><blockquote>尽管这些指标令人鼓舞，但华尔街最近对该公司和股票的一些评论一直持谨慎态度。上个月，Cowen &amp; Co. 的分析师维持了买入建议，但对 Tilray 的评价如下：</blockquote></p><p>   \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.”  Alliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.</p><p><blockquote>“我们正在下调我们的收入和EBITDA预期，因为我们预计加拿大的COVID挑战仍将是一个阻力。此外，TLRY面临着严峻的市场份额竞争，在与Aphria完成合并后，它已经从峰值水平回落并趋于稳定。”Alliance Global Partners对TLRY的评级为中性。分析师不太乐观，将目标价从 32 美元下调至 18 美元。他表示，与 Aphria 的合并对该股有利，但价格在当前水平上是公平的。</blockquote></p><p> <b>Reddit popularity</b></p><p><blockquote><b>Reddit 人气</b></blockquote></p><p> Tilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.</p><p><blockquote>Tilray 股票在 2021 年 2 月见证了令人瞠目结舌的上涨。1 月初至 2 月初期间，股价上涨了 670% 以上，然后急剧回落。</blockquote></p><p> The drivers of bullishness were (1) good earnings results, (2) favorable&nbsp;developments&nbsp;in cannabis regulation, and (2) the signed&nbsp;agreement&nbsp;with Grow Pharma to distribute medical cannabis for patients in the U.K.</p><p><blockquote>看涨的驱动因素是 (1) 良好的盈利业绩，(2) 大麻监管的有利发展，以及 (2) 与 Grow Pharma 签署的向英国患者分销医用大麻的协议。</blockquote></p><p> Reddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.</p><p><blockquote>Reddit论坛似乎也发挥了作用。迷因狂热在一月下旬开始升温，最初是在游戏驿站。很快，TLRY 等其他股票也受益。请参阅下面的股价历史记录以及华尔街投注的评论量。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/12016274a218bd36961f141e5af0556b\" tg-width=\"1160\" tg-height=\"840\" width=\"100%\" height=\"auto\"><span>Figure 4: TLRY stock sentiment and popularity on the WSB.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 4：TLRY 股票情绪和 WSB 上的受欢迎程度。</span></p></blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街迷因的看法</b></blockquote></p><p> The cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.</p><p><blockquote>大麻行业对监管因素非常敏感。缺乏有关新大麻法规的积极消息可能会导致股价长期低迷，就像当前的股价一样。此外，在最近的合并之后，Tilray 还面临着通常的整合风险。</blockquote></p><p></p><p> At the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.</p><p><blockquote>与此同时，随着美国和全球其他地方大麻的医疗和娱乐用途的扩大，机会继续存在。从股票评级和目标价来看，华尔街分析师似乎仍然看好该股。最后，随着Reddit人群的关注，TLRY未来可能会再次成为模因攻击的目标。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/other-memes/tilray-stock-buy-ahead-of-earnings\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://www.thestreet.com/memestocks/other-memes/tilray-stock-buy-ahead-of-earnings","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134472085","content_text":"On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.\nDrug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.\nThe stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.\nThe cannabis market\nIn the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according to the latest data.\nIn 2020, the cannabis market was estimated to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.\nFigure 1: Annual growth of the U.S legal cannabis industry.\nTilray + Aphria merger\nTilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.\nThe Tilray-Aphria merger was justified by expected benefits that included:\n\nmarket leadership in Canada\nfoothold in Europe and better positioning in the U.S.\nlower production costs and synergies\n\nFigure 2: Aphria + Tilray merger.\nWall Street's take\nIn the past several quarters, Tilray has been making good strides on its P&L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:\nFigure 3: Tilray earnings and revenues.\nAnalysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.\nDespite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen & Co.’s analyst maintained her buy recommendation, but stated the following about Tilray:\n\n \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.”\n\nAlliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.\nReddit popularity\nTilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.\nThe drivers of bullishness were (1) good earnings results, (2) favorable developments in cannabis regulation, and (2) the signed agreement with Grow Pharma to distribute medical cannabis for patients in the U.K.\nReddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.\nFigure 4: TLRY stock sentiment and popularity on the WSB.\nWall Street Memes’ take\nThe cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.\nAt the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.","news_type":1,"symbols_score_info":{"TLRY":0.9}},"isVote":1,"tweetType":1,"viewCount":2085,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177549683,"gmtCreate":1627255109642,"gmtModify":1633766939516,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Like.&nbsp;","listText":"Like.&nbsp;","text":"Like.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/177549683","repostId":"1100772026","repostType":4,"isVote":1,"tweetType":1,"viewCount":2688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177558665,"gmtCreate":1627254745057,"gmtModify":1633766946772,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Oops&nbsp;","listText":"Oops&nbsp;","text":"Oops","images":[{"img":"https://static.tigerbbs.com/145f1dd93fd71b90d48a254338157b44","width":"1125","height":"2713"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/177558665","isVote":1,"tweetType":1,"viewCount":2204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172743243,"gmtCreate":1626996334582,"gmtModify":1633769049567,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Test test&nbsp;","listText":"Test test&nbsp;","text":"Test test","images":[{"img":"https://static.tigerbbs.com/dd045de73a512a5cb7e13bba97475412","width":"1125","height":"2974"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172743243","isVote":1,"tweetType":1,"viewCount":833,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172749165,"gmtCreate":1626996272057,"gmtModify":1633769050516,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Test test,&nbsp;","listText":"Test test,&nbsp;","text":"Test test,","images":[{"img":"https://static.tigerbbs.com/fd52ea42109f0d909e996f74dbb0fed8","width":"1125","height":"3060"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172749165","isVote":1,"tweetType":1,"viewCount":675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172757151,"gmtCreate":1626996194373,"gmtModify":1633769052682,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Up… &nbsp;","listText":"Up… &nbsp;","text":"Up…","images":[{"img":"https://static.tigerbbs.com/67259a987726c0d2872fd51b082119ed","width":"1125","height":"2974"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172757151","isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":171636703,"gmtCreate":1626741153602,"gmtModify":1633771556152,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know. [Smile]&nbsp;","listText":"Good to know. [Smile]&nbsp;","text":"Good to know. [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/171636703","repostId":"1121405443","repostType":4,"isVote":1,"tweetType":1,"viewCount":833,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171638041,"gmtCreate":1626741081983,"gmtModify":1633771558049,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know&nbsp;","listText":"Good to know&nbsp;","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171638041","repostId":"1119017482","repostType":4,"isVote":1,"tweetType":1,"viewCount":970,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171633529,"gmtCreate":1626741011561,"gmtModify":1633771559274,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Liked …. Someone pls like my comment? Thanks&nbsp;","listText":"Liked …. Someone pls like my comment? Thanks&nbsp;","text":"Liked …. Someone pls like my comment? Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/171633529","repostId":"2152652683","repostType":4,"isVote":1,"tweetType":1,"viewCount":1017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173179353,"gmtCreate":1626650441672,"gmtModify":1633925349176,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know this&nbsp;","listText":"Good to know this&nbsp;","text":"Good to know this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173179353","repostId":"2152899486","repostType":4,"isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173170061,"gmtCreate":1626650370853,"gmtModify":1633925350303,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know this&nbsp;","listText":"Good to know this&nbsp;","text":"Good to know this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173170061","repostId":"1156209584","repostType":4,"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173144893,"gmtCreate":1626650301612,"gmtModify":1633925351866,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"&nbsp;Ok! Good&nbsp;","listText":"&nbsp;Ok! Good&nbsp;","text":"Ok! Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173144893","repostId":"1168174427","repostType":4,"repost":{"id":"1168174427","kind":"news","pubTimestamp":1626445586,"share":"https://www.laohu8.com/m/news/1168174427?lang=zh_CN&edition=full","pubTime":"2021-07-16 22:26","market":"us","language":"en","title":"Moderna Surges to Record High as Vaccine Maker Added to S&P 500<blockquote>随着疫苗制造商加入标普500，Moderna股价飙升至历史新高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1168174427","media":"Thestreet","summary":"Moderna Inc. (MRNA) shares surged to a fresh record high Friday after the vaccine maker was tipped t","content":"<p>Moderna Inc.&nbsp;(<b>MRNA</b>)&nbsp;shares surged to a fresh record high Friday after the vaccine maker was tipped to enter the S&amp;P 500 benchmark next week.</p><p><blockquote>莫德纳公司（<b>MRNA</b>）在这家疫苗制造商预计将于下周进入标普500基准后，该公司股价周五飙升至历史新高。</blockquote></p><p> Moderna will replaceAlexion Pharmaceuticals&nbsp;(<b>ALXN</b>) &nbsp;in the world's most closely-tracked index, starting at the opening bell on Wednesday July 21, following its$39 billion takeover by Britain's AstraZeneca&nbsp;(<b>AZN</b>)&nbsp;in December of last year.</p><p><blockquote>Moderna将取代Alexion制药公司（<b>ALXN</b>）在被英国阿斯利康(AstraZeneca)以390亿美元收购后，从7月21日星期三开盘开始，成为全球最受关注的指数（<b>AZN</b>）去年12月。</blockquote></p><p> Moderna shares were marked 6% higher in early trading Friday to change hands at $275.92 each, an all-time high that would extend the stock's year-to-date gain to around 165% with a market value of around $111 billion.</p><p><blockquote>Moderna股价周五早盘上涨6%，换手至每股275.92美元，创历史新高，这将使该股今年迄今的涨幅扩大至约165%，市值约为1110亿美元。</blockquote></p><p> Moderna postedstronger-than-expected first quarter earningsof $2.84 per share on May 6, with revenues rising to $1.9 billion. The drugmaker also boosted its full-year vaccine sales forecast to around $19.2 billion for the full 2021 financial year.</p><p><blockquote>Moderna 5月6日公布第一季度每股收益2.84美元，强于预期，营收增至19亿美元。该制药商还将2021财年全年疫苗销售额预测上调至约192亿美元。</blockquote></p><p> Moderna's base plan for 2021 is to produce 800 million doses of its messenger-RNA vaccine, which received emergency approval from the FDA in December of last year, with the aim of \"working hard to get as close to 1 billion doses in 2021 as we can,\" Bancel said in early May.</p><p><blockquote>Moderna 2021年的基本计划是生产8亿剂信使RNA疫苗，该疫苗于去年12月获得FDA的紧急批准，目标是“努力在2021年尽可能多地获得10亿剂疫苗”，Bancel在5月初表示。</blockquote></p><p> \"The feedback from governments around the world requesting high-efficacy mRNA vaccines and variant boosters is overwhelming. We are now actively engaged in discussions and agreements for 2022 with all of the governments we are currently supplying for 2021.\"</p><p><blockquote>“世界各国政府要求高效mRNA疫苗和变异加强剂的反馈是压倒性的。我们现在正在积极与我们目前为2021年供应的所有政府进行2022年的讨论和协议。”</blockquote></p><p> Last month, the groupformally asked the U.S. Food &amp; Drug Administrationfor emergency approval to use allow its coronavirus vaccine to be administered to teenagers over the coming months.</p><p><blockquote>上个月，该组织正式请求美国食品和药物管理局紧急批准在未来几个月内向青少年接种其冠状病毒疫苗。</blockquote></p><p> Moderna, which filed a similar request with European health authorities earlier this week, said late-stage data from its TeenCOVE study \"met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination' with a vaccination efficacy of 100% among the 2,500 participants. A 93% efficacy rate was also noted 14 days after the first of the vaccine's two dose regiment, Moderna said.</p><p><blockquote>Moderna本周早些时候向欧洲卫生当局提出了类似的请求，该公司表示，其TeenCOVE研究的后期数据“达到了主要免疫原性终点，成功地将免疫反应与成人疫苗接种联系起来”，在2,500名参与者中，疫苗接种功效为100%。Moderna表示，在第一次接种两剂疫苗14天后，有效率也达到了93%。</blockquote></p><p> The drugmaker is asking the FDA to issue an Emergency Use Authorization (EUA) notice that will allow its mRNA-1273 to be given to children between the ages of 12 and 18.</p><p><blockquote>该制药商要求FDA发布紧急使用授权(EUA)通知，允许其mRNA-1273用于12至18岁的儿童。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Surges to Record High as Vaccine Maker Added to S&P 500<blockquote>随着疫苗制造商加入标普500，Moderna股价飙升至历史新高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Surges to Record High as Vaccine Maker Added to S&P 500<blockquote>随着疫苗制造商加入标普500，Moderna股价飙升至历史新高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Thestreet</strong><span class=\"h-time small\">2021-07-16 22:26</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Moderna Inc.&nbsp;(<b>MRNA</b>)&nbsp;shares surged to a fresh record high Friday after the vaccine maker was tipped to enter the S&amp;P 500 benchmark next week.</p><p><blockquote>莫德纳公司（<b>MRNA</b>）在这家疫苗制造商预计将于下周进入标普500基准后，该公司股价周五飙升至历史新高。</blockquote></p><p> Moderna will replaceAlexion Pharmaceuticals&nbsp;(<b>ALXN</b>) &nbsp;in the world's most closely-tracked index, starting at the opening bell on Wednesday July 21, following its$39 billion takeover by Britain's AstraZeneca&nbsp;(<b>AZN</b>)&nbsp;in December of last year.</p><p><blockquote>Moderna将取代Alexion制药公司（<b>ALXN</b>）在被英国阿斯利康(AstraZeneca)以390亿美元收购后，从7月21日星期三开盘开始，成为全球最受关注的指数（<b>AZN</b>）去年12月。</blockquote></p><p> Moderna shares were marked 6% higher in early trading Friday to change hands at $275.92 each, an all-time high that would extend the stock's year-to-date gain to around 165% with a market value of around $111 billion.</p><p><blockquote>Moderna股价周五早盘上涨6%，换手至每股275.92美元，创历史新高，这将使该股今年迄今的涨幅扩大至约165%，市值约为1110亿美元。</blockquote></p><p> Moderna postedstronger-than-expected first quarter earningsof $2.84 per share on May 6, with revenues rising to $1.9 billion. The drugmaker also boosted its full-year vaccine sales forecast to around $19.2 billion for the full 2021 financial year.</p><p><blockquote>Moderna 5月6日公布第一季度每股收益2.84美元，强于预期，营收增至19亿美元。该制药商还将2021财年全年疫苗销售额预测上调至约192亿美元。</blockquote></p><p> Moderna's base plan for 2021 is to produce 800 million doses of its messenger-RNA vaccine, which received emergency approval from the FDA in December of last year, with the aim of \"working hard to get as close to 1 billion doses in 2021 as we can,\" Bancel said in early May.</p><p><blockquote>Moderna 2021年的基本计划是生产8亿剂信使RNA疫苗，该疫苗于去年12月获得FDA的紧急批准，目标是“努力在2021年尽可能多地获得10亿剂疫苗”，Bancel在5月初表示。</blockquote></p><p> \"The feedback from governments around the world requesting high-efficacy mRNA vaccines and variant boosters is overwhelming. We are now actively engaged in discussions and agreements for 2022 with all of the governments we are currently supplying for 2021.\"</p><p><blockquote>“世界各国政府要求高效mRNA疫苗和变异加强剂的反馈是压倒性的。我们现在正在积极与我们目前为2021年供应的所有政府进行2022年的讨论和协议。”</blockquote></p><p> Last month, the groupformally asked the U.S. Food &amp; Drug Administrationfor emergency approval to use allow its coronavirus vaccine to be administered to teenagers over the coming months.</p><p><blockquote>上个月，该组织正式请求美国食品和药物管理局紧急批准在未来几个月内向青少年接种其冠状病毒疫苗。</blockquote></p><p> Moderna, which filed a similar request with European health authorities earlier this week, said late-stage data from its TeenCOVE study \"met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination' with a vaccination efficacy of 100% among the 2,500 participants. A 93% efficacy rate was also noted 14 days after the first of the vaccine's two dose regiment, Moderna said.</p><p><blockquote>Moderna本周早些时候向欧洲卫生当局提出了类似的请求，该公司表示，其TeenCOVE研究的后期数据“达到了主要免疫原性终点，成功地将免疫反应与成人疫苗接种联系起来”，在2,500名参与者中，疫苗接种功效为100%。Moderna表示，在第一次接种两剂疫苗14天后，有效率也达到了93%。</blockquote></p><p> The drugmaker is asking the FDA to issue an Emergency Use Authorization (EUA) notice that will allow its mRNA-1273 to be given to children between the ages of 12 and 18.</p><p><blockquote>该制药商要求FDA发布紧急使用授权(EUA)通知，允许其mRNA-1273用于12至18岁的儿童。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/investing/moderna-surges-to-record-high-as-vaccine-maker-added-to-s-p-500\">Thestreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","ALXN":"亚力兄制药","AZN":"阿斯利康"},"source_url":"https://www.thestreet.com/investing/moderna-surges-to-record-high-as-vaccine-maker-added-to-s-p-500","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168174427","content_text":"Moderna Inc. (MRNA) shares surged to a fresh record high Friday after the vaccine maker was tipped to enter the S&P 500 benchmark next week.\nModerna will replaceAlexion Pharmaceuticals (ALXN)  in the world's most closely-tracked index, starting at the opening bell on Wednesday July 21, following its$39 billion takeover by Britain's AstraZeneca (AZN) in December of last year.\nModerna shares were marked 6% higher in early trading Friday to change hands at $275.92 each, an all-time high that would extend the stock's year-to-date gain to around 165% with a market value of around $111 billion.\nModerna postedstronger-than-expected first quarter earningsof $2.84 per share on May 6, with revenues rising to $1.9 billion. The drugmaker also boosted its full-year vaccine sales forecast to around $19.2 billion for the full 2021 financial year.\nModerna's base plan for 2021 is to produce 800 million doses of its messenger-RNA vaccine, which received emergency approval from the FDA in December of last year, with the aim of \"working hard to get as close to 1 billion doses in 2021 as we can,\" Bancel said in early May.\n\"The feedback from governments around the world requesting high-efficacy mRNA vaccines and variant boosters is overwhelming. We are now actively engaged in discussions and agreements for 2022 with all of the governments we are currently supplying for 2021.\"\nLast month, the groupformally asked the U.S. Food & Drug Administrationfor emergency approval to use allow its coronavirus vaccine to be administered to teenagers over the coming months.\nModerna, which filed a similar request with European health authorities earlier this week, said late-stage data from its TeenCOVE study \"met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination' with a vaccination efficacy of 100% among the 2,500 participants. A 93% efficacy rate was also noted 14 days after the first of the vaccine's two dose regiment, Moderna said.\nThe drugmaker is asking the FDA to issue an Emergency Use Authorization (EUA) notice that will allow its mRNA-1273 to be given to children between the ages of 12 and 18.","news_type":1,"symbols_score_info":{"AZN":0.9,"MRNA":0.9,"ALXN":0.9}},"isVote":1,"tweetType":1,"viewCount":559,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173143205,"gmtCreate":1626650066307,"gmtModify":1633925357297,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089409912576010","authorIdStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Ok&nbsp;","listText":"Ok&nbsp;","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173143205","repostId":"2152681854","repostType":4,"isVote":1,"tweetType":1,"viewCount":784,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":171633529,"gmtCreate":1626741011561,"gmtModify":1633771559274,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Liked …. Someone pls like my comment? Thanks&nbsp;","listText":"Liked …. Someone pls like my comment? Thanks&nbsp;","text":"Liked …. Someone pls like my comment? Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/171633529","repostId":"2152652683","repostType":4,"isVote":1,"tweetType":1,"viewCount":1017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806011583,"gmtCreate":1627616029242,"gmtModify":1633757730731,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know&nbsp;","listText":"Good to know&nbsp;","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/806011583","repostId":"2155133648","repostType":4,"isVote":1,"tweetType":1,"viewCount":2629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801855921,"gmtCreate":1627511653763,"gmtModify":1633764399710,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Ok good&nbsp;","listText":"Ok good&nbsp;","text":"Ok good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801855921","repostId":"1179923360","repostType":4,"isVote":1,"tweetType":1,"viewCount":2034,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177549683,"gmtCreate":1627255109642,"gmtModify":1633766939516,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Like.&nbsp;","listText":"Like.&nbsp;","text":"Like.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/177549683","repostId":"1100772026","repostType":4,"isVote":1,"tweetType":1,"viewCount":2688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173149656,"gmtCreate":1626650023875,"gmtModify":1633925358492,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/173149656","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171636703,"gmtCreate":1626741153602,"gmtModify":1633771556152,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know. [Smile]&nbsp;","listText":"Good to know. [Smile]&nbsp;","text":"Good to know. [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/171636703","repostId":"1121405443","repostType":4,"isVote":1,"tweetType":1,"viewCount":833,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890506478,"gmtCreate":1628122445694,"gmtModify":1633753440793,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Nice share&nbsp;","listText":"Nice share&nbsp;","text":"Nice share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/890506478","repostId":"2157488120","repostType":4,"isVote":1,"tweetType":1,"viewCount":2234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803192165,"gmtCreate":1627427169857,"gmtModify":1633765217806,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/803192165","repostId":"1134472085","repostType":4,"repost":{"id":"1134472085","kind":"news","pubTimestamp":1627398407,"share":"https://www.laohu8.com/m/news/1134472085?lang=zh_CN&edition=full","pubTime":"2021-07-27 23:06","market":"us","language":"en","title":"Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134472085","media":"TheStreet","summary":"On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. ","content":"<p>On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.</p><p><blockquote>7 月 28 日星期三，制药商 Tilray 将公布第四财季盈利结果。华尔街模因讨论这是否是一个很好的买入机会。</blockquote></p><p> Drug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.</p><p><blockquote>药品制造商 Tilray 是一家总部位于加拿大的从事医用大麻研究、种植和分销的公司，即将公布第四财季业绩。</blockquote></p><p> The stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.</p><p><blockquote>该股票在 2021 年受到 Redditor 用户的欢迎。随着财报日即将到来，现在的问题是，以目前的价格来看，TLRY 是否值得购买。</blockquote></p><p> <b>The cannabis market</b></p><p><blockquote><b>大麻市场</b></blockquote></p><p> In the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according&nbsp;to the latest data.</p><p><blockquote>在美国，共有34个州加上哥伦比亚特区认为大麻用于医疗用途是合法的。根据最新数据，其中16个已被批准用于娱乐用途。</blockquote></p><p> In 2020, the cannabis market was&nbsp;estimated&nbsp;to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.</p><p><blockquote>根据New Frontier Data的数据，2020年大麻市场价值估计为200亿美元，预计到2025年将达到430亿美元。社会对大麻的接受和生产监管框架的发展似乎推动了增长。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/703f3ea081e0c6f7d74ae53891810b24\" tg-width=\"1240\" tg-height=\"859\" width=\"100%\" height=\"auto\"><span>Figure 1: Annual growth of the U.S legal cannabis industry.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：美国合法大麻产业的年增长率。</span></p></blockquote></p><p> <b>Tilray + Aphria merger</b></p><p><blockquote><b>Tilray + Aphria 合并</b></blockquote></p><p> Tilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.</p><p><blockquote>Tilray 自 2020 年 12 月与 Aphria 合并后开始公开交易。交易完成后，TLRY现在的市值接近60亿美元，是当今最大的大麻公司之一，与同行Canopy Growth并驾齐驱。</blockquote></p><p> The Tilray-Aphria merger was justified by expected benefits that included:</p><p><blockquote>Tilray-Aphria 合并的预期好处包括：</blockquote></p><p> <ol>  <li>market leadership in Canada</li>  <li>foothold in Europe and better positioning in the U.S.</li>  <li>lower production costs and synergies</li> </ol> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6577d25764f8877328fad35a1d14e2d\" tg-width=\"1240\" tg-height=\"659\" width=\"100%\" height=\"auto\"><span>Figure 2: Aphria + Tilray merger.</span></p><p><blockquote><ol><li>加拿大市场领导地位</li><li>在欧洲站稳脚跟，在美国有更好的定位。</li><li>降低生产成本和协同效应</li></ol><p class=\"t-img-caption\"><span>图2：Aphria+Tilray合并。</span></p></blockquote></p><p> <b>Wall Street's take</b></p><p><blockquote><b>华尔街的观点</b></blockquote></p><p> In the past several quarters, Tilray has been making good strides on its P&amp;L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:</p><p><blockquote>在过去的几个季度里，Tilray 的损益表取得了良好的进展。2020年，该公司报告的收入逐步改善，全年达到2.1亿美元。它还成功扭转了自去年之前积累的大幅净亏损状况。见下文：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ee35f0e1943629cac6c9a31ffdb5ca8\" tg-width=\"1240\" tg-height=\"481\" width=\"100%\" height=\"auto\"><span>Figure 3: Tilray earnings and revenues.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 3：Tilray 盈利和收入。</span></p></blockquote></p><p> Analysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.</p><p><blockquote>分析师目前将 TLRY 评级为适度买入，平均目标价接近 21 美元，潜在上涨空间为 52%。与 Aphria 的合并对大多数分析师产生了积极影响。</blockquote></p><p> Despite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen &amp; Co.’s analyst&nbsp;maintained&nbsp;her buy recommendation, but stated the following about Tilray:</p><p><blockquote>尽管这些指标令人鼓舞，但华尔街最近对该公司和股票的一些评论一直持谨慎态度。上个月，Cowen &amp; Co. 的分析师维持了买入建议，但对 Tilray 的评价如下：</blockquote></p><p>   \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.”  Alliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.</p><p><blockquote>“我们正在下调我们的收入和EBITDA预期，因为我们预计加拿大的COVID挑战仍将是一个阻力。此外，TLRY面临着严峻的市场份额竞争，在与Aphria完成合并后，它已经从峰值水平回落并趋于稳定。”Alliance Global Partners对TLRY的评级为中性。分析师不太乐观，将目标价从 32 美元下调至 18 美元。他表示，与 Aphria 的合并对该股有利，但价格在当前水平上是公平的。</blockquote></p><p> <b>Reddit popularity</b></p><p><blockquote><b>Reddit 人气</b></blockquote></p><p> Tilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.</p><p><blockquote>Tilray 股票在 2021 年 2 月见证了令人瞠目结舌的上涨。1 月初至 2 月初期间，股价上涨了 670% 以上，然后急剧回落。</blockquote></p><p> The drivers of bullishness were (1) good earnings results, (2) favorable&nbsp;developments&nbsp;in cannabis regulation, and (2) the signed&nbsp;agreement&nbsp;with Grow Pharma to distribute medical cannabis for patients in the U.K.</p><p><blockquote>看涨的驱动因素是 (1) 良好的盈利业绩，(2) 大麻监管的有利发展，以及 (2) 与 Grow Pharma 签署的向英国患者分销医用大麻的协议。</blockquote></p><p> Reddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.</p><p><blockquote>Reddit论坛似乎也发挥了作用。迷因狂热在一月下旬开始升温，最初是在游戏驿站。很快，TLRY 等其他股票也受益。请参阅下面的股价历史记录以及华尔街投注的评论量。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/12016274a218bd36961f141e5af0556b\" tg-width=\"1160\" tg-height=\"840\" width=\"100%\" height=\"auto\"><span>Figure 4: TLRY stock sentiment and popularity on the WSB.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 4：TLRY 股票情绪和 WSB 上的受欢迎程度。</span></p></blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街迷因的看法</b></blockquote></p><p> The cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.</p><p><blockquote>大麻行业对监管因素非常敏感。缺乏有关新大麻法规的积极消息可能会导致股价长期低迷，就像当前的股价一样。此外，在最近的合并之后，Tilray 还面临着通常的整合风险。</blockquote></p><p></p><p> At the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.</p><p><blockquote>与此同时，随着美国和全球其他地方大麻的医疗和娱乐用途的扩大，机会继续存在。从股票评级和目标价来看，华尔街分析师似乎仍然看好该股。最后，随着Reddit人群的关注，TLRY未来可能会再次成为模因攻击的目标。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Stock: Buy Ahead Of Earnings?<blockquote>Tilray 股票：在财报公布前买入？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-07-27 23:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p>On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.</p><p><blockquote>7 月 28 日星期三，制药商 Tilray 将公布第四财季盈利结果。华尔街模因讨论这是否是一个很好的买入机会。</blockquote></p><p> Drug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.</p><p><blockquote>药品制造商 Tilray 是一家总部位于加拿大的从事医用大麻研究、种植和分销的公司，即将公布第四财季业绩。</blockquote></p><p> The stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.</p><p><blockquote>该股票在 2021 年受到 Redditor 用户的欢迎。随着财报日即将到来，现在的问题是，以目前的价格来看，TLRY 是否值得购买。</blockquote></p><p> <b>The cannabis market</b></p><p><blockquote><b>大麻市场</b></blockquote></p><p> In the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according&nbsp;to the latest data.</p><p><blockquote>在美国，共有34个州加上哥伦比亚特区认为大麻用于医疗用途是合法的。根据最新数据，其中16个已被批准用于娱乐用途。</blockquote></p><p> In 2020, the cannabis market was&nbsp;estimated&nbsp;to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.</p><p><blockquote>根据New Frontier Data的数据，2020年大麻市场价值估计为200亿美元，预计到2025年将达到430亿美元。社会对大麻的接受和生产监管框架的发展似乎推动了增长。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/703f3ea081e0c6f7d74ae53891810b24\" tg-width=\"1240\" tg-height=\"859\" width=\"100%\" height=\"auto\"><span>Figure 1: Annual growth of the U.S legal cannabis industry.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：美国合法大麻产业的年增长率。</span></p></blockquote></p><p> <b>Tilray + Aphria merger</b></p><p><blockquote><b>Tilray + Aphria 合并</b></blockquote></p><p> Tilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.</p><p><blockquote>Tilray 自 2020 年 12 月与 Aphria 合并后开始公开交易。交易完成后，TLRY现在的市值接近60亿美元，是当今最大的大麻公司之一，与同行Canopy Growth并驾齐驱。</blockquote></p><p> The Tilray-Aphria merger was justified by expected benefits that included:</p><p><blockquote>Tilray-Aphria 合并的预期好处包括：</blockquote></p><p> <ol>  <li>market leadership in Canada</li>  <li>foothold in Europe and better positioning in the U.S.</li>  <li>lower production costs and synergies</li> </ol> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6577d25764f8877328fad35a1d14e2d\" tg-width=\"1240\" tg-height=\"659\" width=\"100%\" height=\"auto\"><span>Figure 2: Aphria + Tilray merger.</span></p><p><blockquote><ol><li>加拿大市场领导地位</li><li>在欧洲站稳脚跟，在美国有更好的定位。</li><li>降低生产成本和协同效应</li></ol><p class=\"t-img-caption\"><span>图2：Aphria+Tilray合并。</span></p></blockquote></p><p> <b>Wall Street's take</b></p><p><blockquote><b>华尔街的观点</b></blockquote></p><p> In the past several quarters, Tilray has been making good strides on its P&amp;L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:</p><p><blockquote>在过去的几个季度里，Tilray 的损益表取得了良好的进展。2020年，该公司报告的收入逐步改善，全年达到2.1亿美元。它还成功扭转了自去年之前积累的大幅净亏损状况。见下文：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ee35f0e1943629cac6c9a31ffdb5ca8\" tg-width=\"1240\" tg-height=\"481\" width=\"100%\" height=\"auto\"><span>Figure 3: Tilray earnings and revenues.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 3：Tilray 盈利和收入。</span></p></blockquote></p><p> Analysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.</p><p><blockquote>分析师目前将 TLRY 评级为适度买入，平均目标价接近 21 美元，潜在上涨空间为 52%。与 Aphria 的合并对大多数分析师产生了积极影响。</blockquote></p><p> Despite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen &amp; Co.’s analyst&nbsp;maintained&nbsp;her buy recommendation, but stated the following about Tilray:</p><p><blockquote>尽管这些指标令人鼓舞，但华尔街最近对该公司和股票的一些评论一直持谨慎态度。上个月，Cowen &amp; Co. 的分析师维持了买入建议，但对 Tilray 的评价如下：</blockquote></p><p>   \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.”  Alliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.</p><p><blockquote>“我们正在下调我们的收入和EBITDA预期，因为我们预计加拿大的COVID挑战仍将是一个阻力。此外，TLRY面临着严峻的市场份额竞争，在与Aphria完成合并后，它已经从峰值水平回落并趋于稳定。”Alliance Global Partners对TLRY的评级为中性。分析师不太乐观，将目标价从 32 美元下调至 18 美元。他表示，与 Aphria 的合并对该股有利，但价格在当前水平上是公平的。</blockquote></p><p> <b>Reddit popularity</b></p><p><blockquote><b>Reddit 人气</b></blockquote></p><p> Tilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.</p><p><blockquote>Tilray 股票在 2021 年 2 月见证了令人瞠目结舌的上涨。1 月初至 2 月初期间，股价上涨了 670% 以上，然后急剧回落。</blockquote></p><p> The drivers of bullishness were (1) good earnings results, (2) favorable&nbsp;developments&nbsp;in cannabis regulation, and (2) the signed&nbsp;agreement&nbsp;with Grow Pharma to distribute medical cannabis for patients in the U.K.</p><p><blockquote>看涨的驱动因素是 (1) 良好的盈利业绩，(2) 大麻监管的有利发展，以及 (2) 与 Grow Pharma 签署的向英国患者分销医用大麻的协议。</blockquote></p><p> Reddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.</p><p><blockquote>Reddit论坛似乎也发挥了作用。迷因狂热在一月下旬开始升温，最初是在游戏驿站。很快，TLRY 等其他股票也受益。请参阅下面的股价历史记录以及华尔街投注的评论量。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/12016274a218bd36961f141e5af0556b\" tg-width=\"1160\" tg-height=\"840\" width=\"100%\" height=\"auto\"><span>Figure 4: TLRY stock sentiment and popularity on the WSB.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图 4：TLRY 股票情绪和 WSB 上的受欢迎程度。</span></p></blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街迷因的看法</b></blockquote></p><p> The cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.</p><p><blockquote>大麻行业对监管因素非常敏感。缺乏有关新大麻法规的积极消息可能会导致股价长期低迷，就像当前的股价一样。此外，在最近的合并之后，Tilray 还面临着通常的整合风险。</blockquote></p><p></p><p> At the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.</p><p><blockquote>与此同时，随着美国和全球其他地方大麻的医疗和娱乐用途的扩大，机会继续存在。从股票评级和目标价来看，华尔街分析师似乎仍然看好该股。最后，随着Reddit人群的关注，TLRY未来可能会再次成为模因攻击的目标。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/other-memes/tilray-stock-buy-ahead-of-earnings\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://www.thestreet.com/memestocks/other-memes/tilray-stock-buy-ahead-of-earnings","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134472085","content_text":"On Wednesday, July 28, drug manufacturer Tilray will report fiscal fourth quarter earnings results. Wall Street Memes discusses whether this may be a good buying opportunity.\nDrug manufacturer Tilray, a Canadian-based company engaged in research, cultivation, and distribution of medical cannabis, is about to report its fiscal fourth quarter results.\nThe stock has been popular among Redditors in 2021. With earnings day around the corner, the question now is whether TLRY might be a good buy at current prices.\nThe cannabis market\nIn the United States, a total of 34 states plus the District of Columbia consider marijuana legal for medicinal use. Among these, 16 have approved recreational use,according to the latest data.\nIn 2020, the cannabis market was estimated to be valued at $20 billion by New Frontier Data, and it is projected to reach $43 billion by 2025. Growth seems to be fueled by social acceptance of cannabis and the development of a regulatory framework for production.\nFigure 1: Annual growth of the U.S legal cannabis industry.\nTilray + Aphria merger\nTilray has been trading publicly since December 2020, after merging with Aphria. Following the deal, TLRY now has a market cap of close to $6 billion – one of the largest cannabis companies today, alongside peer Canopy Growth.\nThe Tilray-Aphria merger was justified by expected benefits that included:\n\nmarket leadership in Canada\nfoothold in Europe and better positioning in the U.S.\nlower production costs and synergies\n\nFigure 2: Aphria + Tilray merger.\nWall Street's take\nIn the past several quarters, Tilray has been making good strides on its P&L. In 2020, the company reported progressively better revenue that reached $210 million for the year. It also managed to reverse a sharp net loss position that had been accumulating since prior to last year. See below:\nFigure 3: Tilray earnings and revenues.\nAnalysts currently rate TLRY as a moderate buy, with an average target price of nearly $21 for a potential upside of 52%. The merger with Aphria weighed positively for most analysts.\nDespite the encouraging metrics, some of Wall Street’s commentary around the company and stock has been cautious lately. Last month, Cowen & Co.’s analyst maintained her buy recommendation, but stated the following about Tilray:\n\n \"We are taking down our revenue and EBITDA estimates, as we expect COVID challenges in Canada to remain a headwind. In addition, TLRY faces tough market share comps, where it has retraced from peak levels to stabilize following the completion of the merger with Aphria.”\n\nAlliance Global Partners has a neutral recommendation on TLRY. Less optimistic, the analyst has lowered the target price from $32 to $18.Accordingto him, the merger with Aphria is beneficial for the stock, but the price is fair at current levels.\nReddit popularity\nTilray stock witnessed an eye-popping rally in February 2021. Shares climbed more than 670% between early January and early February, before pulling back sharply.\nThe drivers of bullishness were (1) good earnings results, (2) favorable developments in cannabis regulation, and (2) the signed agreement with Grow Pharma to distribute medical cannabis for patients in the U.K.\nReddit forums certainly seem to have played a role as well. Meme mania picked up steam in late January, at first with GameStop. Soon enough, other stocks like TLRY also benefited. See below the share price history, alongside the volume of comments on WallStreetBets.\nFigure 4: TLRY stock sentiment and popularity on the WSB.\nWall Street Memes’ take\nThe cannabis industry is very sensitive to regulatory factors. Lack of positive news regarding new cannabis regulations can lead to prolonged periods of malaise in stock price, like the current one. In addition, Tilray faces the usual integration risks, following the recent merger.\nAt the same time, opportunities continue to exist as medicinal and recreational use of cannabis in the U.S and elsewhere globally expand. Judging by stock ratings and price targets, Wall Street analysts still seem optimistic about the stock. Lastly, with the Reddit crowd paying attention, TLRY could potentially become the target of a meme attack again in the future.","news_type":1,"symbols_score_info":{"TLRY":0.9}},"isVote":1,"tweetType":1,"viewCount":2085,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173170061,"gmtCreate":1626650370853,"gmtModify":1633925350303,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good to know this&nbsp;","listText":"Good to know this&nbsp;","text":"Good to know this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173170061","repostId":"1156209584","repostType":4,"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173143039,"gmtCreate":1626650042921,"gmtModify":1633925357895,"author":{"id":"4089409912576010","authorId":"4089409912576010","name":"BBKK","avatar":"https://static.tigerbbs.com/50e16ff101160c30777ec2fc744874fc","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089409912576010","idStr":"4089409912576010"},"themes":[],"title":"","htmlText":"Good day&nbsp;","listText":"Good day&nbsp;","text":"Good day","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173143039","repostId":"1183956332","repostType":4,"isVote":1,"tweetType":1,"viewCount":455,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}